Page: PRIME: priority medicines-2025/1/6

Document: Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 9-12 December 2024-2025/1/6

Document: List of medicines currently in PRIME scheme-2025/1/6

Document: Checklist for annual updates for parallel distribution: guidance for industry-2025/1/6

Document: Checklist for initial notifications for parallel distribution: guidance for industry-2025/1/6

Page: Certification of medicinal products-2025/1/6

Document: Information package for certificates of medicinal products issued by the European Medicines Agency-2025/1/6

Page: Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline-2024/2/23

Page: Non-clinical and clinical evaluation of antiviral medicinal products and monoclonal antibodies for the prevention and treatment of COVID-19 - Scientific guideline-2024/2/22

Document: Reflection paper on investigation of pharmacokinetics in the obese population - Scientific guideline-2024/2/14